FDA mulling approval of second COVID-19 booster shot; Fauci says perhaps ‘in the fall’

Get the latest BPR news delivered free to your inbox daily. SIGN UP HERE

The Food and Drug Administration (FDA) has publicly signaled their intent for a second COVID-19 booster following reports that this was never in question.

Alison Hunt, a spokesperson for the FDA, said the FDA is, “continually looking at the emerging data on the pandemic and variants,” CNN reported.

“As more date becomes available about the safety and effectiveness of COVID-19 vaccines,” Hunt stated, “including the use of a booster does, we will continue to evaluate the rapidly changing science and keep the public informed.”

Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, suggested it would be best to administer a second booster, if needed, in the fall or winter, when a new variant is more likely to emerge, according to CNN.

While Hunt was expressing uncertainty about this outcome and insisted that, “Any determination that additional booster doses are needed will be based on data available to the agency,” representatives from the various agencies and industries involved in the development and distribution of these COVID-19 vaccines have raised doubts as to whether the “data” is what is driving the push for ongoing injections.

Pfizer CEO Albert Bourla had said in a January interview that, “What I’m hoping [is] that we will have a vaccine that you will have to do once a year. Once a year it is easier to convince people to do it.” While he claims “it is an ideal solution” for public health, he left out the commercial incentive for himself as it has been reported Pfizer may be earning as much as $1,000/second from their COVID shots.

Then, just this past Tuesday, Project Veritas released an exposé showing the FDA Executive Officer of Countermeasures Initiative Christopher Cole discussing the inevitability of further approvals and annual shots. “If they [Big Pharma] can get every person required at [to get] an annual vaccine,” Cole explained, “that is a recurring return of money going into their [Big Pharma] company.”

“So, you’ll have to get an annual shot,” Cole said, “I mean, it hasn’t been formally announced yet ’cause they don’t want to rile everyone up.” He later added, “I think what’s going to happen is it’s going to be a gradual thing.”

Though an official FDA statement declared Cole’s views did not reflect the views of the FDA, the FDA does appear to be making a gradual push toward this policy with their latest announcement. Cole’s comments in the video might also explain a recent announcement out of the White House.

In the video, Cole touched on the Emergency Use Authorization Act (EUA) that allows for the acceleration of the approval process stating in part, “Well, they’re all approved under an emergency…they’re all being approved under that standard.”

The emergency declaration for COVID-19 was set to expire on March 1, the same date that President Biden will be making his first State of the Union address. However, Biden said on Friday that the national emergency will be extended due to the ongoing risk in a letter addressed to the Speaker of the House of Representatives and the President of the Senate.

“There remains a need to continue this national emergency,” Biden wrote before later adding, “and it is essential to continue to combat and respond to COVID-19 with the full capacity and capability of the Federal Government.”


Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.
Kevin Haggerty


We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

PLEASE JOIN OUR NEW COMMENT SYSTEM! We love hearing from our readers and invite you to join us for feedback and great conversation. If you've commented with us before, we'll need you to re-input your email address for this. The public will not see it and we do not share it.

Latest Articles